Awakn Life Sciences Corp (TSE:AWKN) has released an update.
Awakn Life Sciences Corp. has successfully closed the first tranche of its private placement, raising $131,428 through the issuance of 285,714 units at $0.46 each. These funds are earmarked for the company’s general working capital to advance its clinical-stage biotech endeavors, particularly focusing on treatments for Alcohol Use Disorder. The securities issued are subject to a four-month hold period and must adhere to regulatory approval and securities legislation.
For further insights into TSE:AWKN stock, check out TipRanks’ Stock Analysis page.
